![]()
|
|
||||||||
(Received for publication, April 16, 1996, and in revised form, July 10, 1996)
From the Previously, we identified a novel human
cytochrome P450 cDNA that is inducible by
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and
represents the first member of a new subfamily designated cytochrome
P4501B1 (CYP1B1; Sutter, T. R., Tang, Y. M., Hayes, C. L.,
Wo, Y. P., Jabs, E. W., Li, X., Yin, H., Cody, C. W., and Greenlee, W.
F. (1994) J. Biol. Chem. 269, 13092-13099). Here, we
report on the isolation and initial characterization of the
CYP1B1 gene. The CYP1B1 gene maps to human
chromosome 2 at 2p21-22 and contains three exons and two introns. The
putative open reading frame starts in the second exon and is 1629 base
pairs in length. Southern analysis using DNA probes directed to each of
the three exons confirmed that CYP1B1 is a single copy
gene. Human CYP1B1 differs from its two most closely
related members of the cytochrome P450 superfamily, CYP1A1
and CYP1A2, in the number of exons (3 versus 7)
and chromosome location (2 versus 15). A single
transcription initiation site was identified by primer extension
analysis and S1 nuclease mapping. Based on nucleotide sequence
analysis, the CYP1B1 gene lacks a consensus TATA box in the
promoter region and contains nine TCDD-responsive enhancer core binding
motifs (5
Volume 271, Number 45,
Issue of November 8, 1996
pp. 28324-28330
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
,
,
,
Department of Pharmacology and Toxicology,
Purdue University, West Lafayette, Indiana 47907, the
§ Oncology Center and Departments of Pathology and Oncology
and ¶ Department of Environmental Health Sciences, Johns Hopkins
Medical Institutions, Baltimore, Maryland 21205, and the
Department of Pharmacology and Molecular Toxicology, University
of Massachusetts Medical Center, Worcester, Massachusetts 01655
-GCGTG-3
) located within a 2.5-kilobase pair genomic
fragment 5
-ward of the transcription initiation start site. Deletion
analysis of chloramphenicol acetyltransferase reporter gene constructs
containing 5
CYP1B1 genomic fragments indicates that a
region from
1022 to
835 containing three of the nine core binding
motifs contributes to the TCDD-inducible expression of
CYP1B1.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. B. Halberg, M. C. Larsen, T. L. Elmergreen, A. Y. Ko, A. A. Irving, L. Clipson, and C. R. Jefcoate Cyp1b1 Exerts Opposing Effects on Intestinal Tumorigenesis via Exogenous and Endogenous Substrates Cancer Res., September 15, 2008; 68(18): 7394 - 7402. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Beuten, J. A.L. Gelfond, J. J. Byrne, I. Balic, A. C. Crandall, T. L. Johnson-Pais, I. M. Thompson, D. K. Price, and R. J. Leach CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians Carcinogenesis, September 1, 2008; 29(9): 1751 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Paracchini, S. Raimondi, I. T. Gram, D. Kang, N. A. Kocabas, V. N. Kristensen, D. Li, F. F. Parl, T. Rylander-Rudqvist, P. Soucek, et al. Meta- and Pooled Analyses of the Cytochrome P-450 1B1 Val432Leu Polymorphism and Breast Cancer: A HuGE-GSEC Review Am. J. Epidemiol., January 15, 2007; 165(2): 115 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Sissung, D. K. Price, A. Sparreboom, and W. D. Figg Pharmacogenetics and Regulation of Human Cytochrome P450 1B1: Implications in Hormone-Mediated Tumor Metabolism and a Novel Target for Therapeutic Intervention Mol. Cancer Res., March 1, 2006; 4(3): 135 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Chun, S.-K. Lee, and M. Y. Kim MODULATION OF HUMAN CYTOCHROME P450 1B1 EXPRESSION BY 2,4,3',5'-TETRAMETHOXYSTILBENE Drug Metab. Dispos., December 1, 2005; 33(12): 1771 - 1776. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tokizane, H. Shiina, M. Igawa, H. Enokida, S. Urakami, T. Kawakami, T. Ogishima, S. T. Okino, L.-C. Li, Y. Tanaka, et al. Cytochrome P450 1B1 Is Overexpressed and Regulated by Hypomethylation in Prostate Cancer Clin. Cancer Res., August 15, 2005; 11(16): 5793 - 5801. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Aklillu, S. Ovrebo, I. V. Botnen, C. Otter, and M. Ingelman-Sundberg Characterization of Common CYP1B1 Variants with Different Capacity for Benzo[a]pyrene-7,8-Dihydrodiol Epoxide Formation from Benzo[a]pyrene Cancer Res., June 15, 2005; 65(12): 5105 - 5111. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Handley-Goldstone, M. W. Grow, and J. J. Stegeman Cardiovascular Gene Expression Profiles of Dioxin Exposure in Zebrafish Embryos Toxicol. Sci., May 1, 2005; 85(1): 683 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Port, K. Yamaguchi, B. Du, M. De Lorenzo, M. Chang, P. M. Heerdt, L. Kopelovich, C. B. Marcus, N. K. Altorki, K. Subbaramaiah, et al. Tobacco smoke induces CYP1B1 in the aerodigestive tract Carcinogenesis, November 1, 2004; 25(11): 2275 - 2281. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Saijo, F. Sata, H. Yamada, K. Suzuki, S. Sasaki, T. Kondo, Y.Y. Gong, E.H. Kato, S. Shimada, M. Morikawa, et al. Ah receptor, CYP1A1, CYP1A2 and CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss Mol. Hum. Reprod., October 1, 2004; 10(10): 729 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rodriguez-Melendez, J. B. Griffin, and J. Zempleni Biotin Supplementation Increases Expression of the Cytochrome P450 1B1 Gene in Jurkat Cells, Increasing the Occurrence of Single-Stranded DNA Breaks J. Nutr., September 1, 2004; 134(9): 2222 - 2228. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Panicker, A. K. Mandal, A. B. M. Reddy, V. K. Gothwal, and S. E. Hasnain Correlations of Genotype with Phenotype in Indian Patients with Primary Congenital Glaucoma Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1149 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Spink, B. H. Katz, M. M. Hussain, B. T. Pentecost, Z. Cao, and B. C. Spink Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells Carcinogenesis, December 1, 2003; 24(12): 1941 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. M. Reddy, S. G. Panicker, A. K. Mandal, S. E. Hasnain, and D. Balasubramanian Identification of R368H as a Predominant CYP1B1 Allele Causing Primary Congenital Glaucoma in Indian Patients Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4200 - 4203. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Mammen, G. S. Pittman, Y. Li, F. Abou-Zahr, B. A. Bejjani, D. A. Bell, P. T. Strickland, and T. R. Sutter Single amino acid mutations, but not common polymorphisms, decrease the activity of CYP1B1 against (-)benzo[a]pyrene-7R-trans-7,8-dihydrodiol Carcinogenesis, July 1, 2003; 24(7): 1247 - 1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tsuchiya, M. Nakajima, and T. Yokoi Critical Enhancer Region to Which AhR/ARNT and Sp1 Bind in the Human CYP1B1 Gene J. Biochem., May 1, 2003; 133(5): 583 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Sitorus, S M Ardjo, B Lorenz, and M Preising CYP1B1 gene analysis in primary congenital glaucoma in Indonesian and European patients J. Med. Genet., January 1, 2003; 40(1): e9 - 9. [Full Text] [PDF] |
||||
![]() |
S. G. Panicker, A. B. M. Reddy, A. K. Mandal, N. Ahmed, H. A. Nagarajaram, S. E. Hasnain, and D. Balasubramanian Identification of Novel Mutations Causing Familial Primary Congenital Glaucoma in Indian Pedigrees Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1358 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Aklillu, M. Oscarson, M. Hidestrand, B. Leidvik, C. Otter, and M. Ingelman-Sundberg Functional Analysis of Six Different Polymorphic CYP1B1 Enzyme Variants Found in an Ethiopian Population Mol. Pharmacol., March 1, 2002; 61(3): 586 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-S. Chua, E. Kashiyama, T. D. Bradshaw, S. F. Stinson, E. Brantley, E. A. Sausville, and M. F. G. Stevens Role of CYP1A1 in Modulation of Antitumor Properties of the Novel Agent 2-(4-Amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in Human Breast Cancer Cells Cancer Res., September 1, 2000; 60(18): 5196 - 5203. [Abstract] [Full Text] |
||||
![]() |
C. R. Jefcoate, J. G. Liehr, R. J. Santen, T. R. Sutter, J. D. Yager, W. Yue, S. J. Santner, R. Tekmal, L. Demers, R. Pauley, et al. Chapter 5: Tissue-Specific Synthesis and Oxidative Metabolism of Estrogens J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 95 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Shehin, R. O. Stephenson, and W. F. Greenlee Transcriptional Regulation of the Human CYP1B1 Gene. EVIDENCE FOR INVOLVEMENT OF AN ARYL HYDROCARBON RECEPTOR RESPONSE ELEMENT IN CONSTITUTIVE EXPRESSION J. Biol. Chem., March 15, 2000; 275(10): 6770 - 6776. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zheng, D.-W. Xie, F. Jin, J.-R. Cheng, Q. Dai, W.-Q. Wen, X.-O. Shu, and Y.-T. Gao Genetic Polymorphism of Cytochrome P450-1B1 and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2000; 9(2): 147 - 150. [Abstract] [Full Text] |
||||
![]() |
M. C.E. McFadyen, S. Breeman, S. Payne, C. Stirk, I. D. Miller, W. T. Melvin, and G. I. Murray Immunohistochemical Localization of Cytochrome P450 CYP1B1 in Breast Cancer with Monoclonal Antibodies Specific for CYP1B1 J. Histochem. Cytochem., November 1, 1999; 47(11): 1457 - 1464. [Abstract] [Full Text] |
||||
![]() |
W. G.R. Angus, M. C. Larsen, and C. R. Jefcoate Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status Carcinogenesis, June 1, 1999; 20(6): 947 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Plásilová, I. Stoilov, M. Sarfarazi, L. Kádasi, E. Feráková, and V. Ferák Identification of a single ancestral CYP1B1 mutation in Slovak Gypsies (Roms) affected with primary congenital glaucoma J. Med. Genet., April 1, 1999; 36(4): 290 - 294. [Abstract] [Full Text] |
||||
![]() |
J. T. M. Buters, S. Sakai, T. Richter, T. Pineau, D. L. Alexander, U. Savas, J. Doehmer, J. M. Ward, C. R. Jefcoate, and F. J. Gonzalez Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas PNAS, March 2, 1999; 96(5): 1977 - 1982. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Ricci, D. G. Toscano, C. J. Mattingly, and W. A. Toscano Jr. Estrogen Receptor Reduces CYP1A1 Induction in Cultured Human Endometrial Cells J. Biol. Chem., February 5, 1999; 274(6): 3430 - 3438. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Spencer, S. A. Masten, K. M. Lanier, X. Yang, J. A. Grassman, C. R. Miller, T. R. Sutter, G. W. Lucier, and N. J. Walker Quantitative Analysis of Constitutive and 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced Cytochrome P450 1B1 Expression in Human Lymphocytes Cancer Epidemiol. Biomarkers Prev., February 1, 1999; 8(2): 139 - 146. [Abstract] [Full Text] |
||||
![]() |
Y. M. Tang, G.-F. Chen, P. A. Thompson, D.-X. Lin, N. P. Lang, and F. F. Kadlubar Development of an AntiPeptide Antibody That Binds to the C-Terminal Region of Human CYP1B1 Drug Metab. Dispos., February 1, 1999; 27(2): 274 - 280. [Abstract] [Full Text] |
||||
![]() |
K. Kurose, M. Tohkin, and M. Fukuhara A Novel Positive Regulatory Element That Enhances Hamster CYP2A8 Gene Expression Mediated by Xenobiotic Responsive Element Mol. Pharmacol., February 1, 1999; 55(2): 279 - 287. [Abstract] [Full Text] |
||||
![]() |
L. Zhang, U. Savas, D. L. Alexander, and C. R. Jefcoate Characterization of the Mouse Cyp1B1 Gene. IDENTIFICATION OF AN ENHANCER REGION THAT DIRECTS ARYL HYDROCARBON RECEPTOR-MEDIATED CONSTITUTIVE AND INDUCED EXPRESSION J. Biol. Chem., February 27, 1998; 273(9): 5174 - 5183. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. P. Wo, J. Stewart, and W. F. Greenlee Functional Analysis of the Promoter for the Human CYP1B1 Gene J. Biol. Chem., October 17, 1997; 272(42): 26702 - 26707. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Sinal and J. R. Bend Aryl Hydrocarbon Receptor-Dependent Induction of Cyp1a1 by Bilirubin in Mouse Hepatoma Hepa 1c1c7 Cells Mol. Pharmacol., October 1, 1997; 52(4): 590 - 599. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |